(The 2025 Vashon Island Film Fest runs August 7-10 on beautiful Vashon Island, just a ferry ride from Seattle. HtN has coverage coming your way like this Shuffle movie review by Alan Motley! Seen it? Join the conversation with HtN on our Letterboxd Page.)
There’s a moment in Shuffle when the pattern snaps into view: relapse isn’t a tragedy to the system—it’s a business model. Director Benjamin Flaherty (himself in recovery) traces how a network of brokers, clinics, and sober homes cycles insured people through treatment again and again, harvesting “liquid gold” urine tests and billing codes while lives unravel. It’s not just Florida lore—it’s a nationwide playbook.
Flaherty works small to reveal something enormous. He follows three people over years, narrating with a steady, lived-in voice and weaving in whistleblowers—an FBI informant, an insurance analyst, a former facility executive—to show how policy failures and profiteering lock people into the churn. The film won SXSW’s Documentary Feature Competition, and you can see why: it balances intimate character study with a furious, clearly sourced investigation.
Stylistically, Shuffle mixes street-level vérité with occasional rough-hewn animations—scratches of feeling that keep the film from drowning in paperwork and statutes. Once you grasp how relapse maps to revenue, every “transfer” reads like trafficking dressed in clinical language.
Watching from the Pacific Northwest, I couldn’t help clocking the spread beyond Florida. The film makes the point, and public reporting backs it up: the “shuffle” model shows up in other states with sunshine and insurance money—California, Arizona—and the incentives don’t stop at state lines. That national shadow makes Shuffle feel urgent on Vashon too.
Bottom line: A potent blend of testimony and investigation that turns a confusing industry into a clear moral emergency—and demands we stop rewarding relapse with revenue.
– Alan Motley (@alanmotley)
Post a Comment
